Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta by unknown
Signal Transduction by Immunoglobulin Is Mediated 
Through  Igc~ and Ig~ 
By Mercedes Sanchez, Ziva Misulovin, Anne L. Burkhardt,* 
Sandeep Mahajan,* Thais Costa, Roland Franke, Joseph B. Bolen,* 
and Michel Nussenzweig 
From the Howard Hughes Medical Institute, The Rockefeller University; and the *Department 
of Molecular Biology, Bristol-Meyers Squibb Pharmaceutical Research Institute 
Summary 
Immunoglobulin (Ig) antigen receptors are composed of a noncovalently-associated complex of 
Ig and two other proteins, Igo~ and Ig3. The cytoplasmic domain of both of these Ig associated 
proteins contains a consensus sequence that is shared with the signaling proteins of the T  cell 
and Fc receptor. To test the idea that Igc~-IgB heterodimers are the signaling components of 
the Ig receptor, we have studied Ig mutations that interfere with signal transduction. We find 
that specific mutations in the transmembrane domain of Ig that inactivate Ca  2+ and phosphory- 
lation responses also uncouple IgM from Igoe-Ig/3. These results define amino acid residues that 
are essential for the assembly of the Ig receptor. Further, receptor activity can be fully reconstituted 
in Ca  2+  flux and phosphorylation assays by fusing the cytoplasmic domain of Igct with the 
mutant Igs. In contrast, fusion of the cytoplasmic domain of Ig~ to the inactive Ig reconstitutes 
only Ca  z+  responses. Thus,  Igor and IgB are both necessary and sufficient to mediate signal 
transduction by the Ig receptor in B cells.  In addition,  our results suggest that IgoL and IgB 
can activate different signaling pathways. 
M 
embrane Ig plays a central role in the generation of 
immune responses.  However, there has been limited 
progress towards understanding the molecular mechanism of 
action of this receptor. Two features of receptor Igs have made 
functional analysis a difficult problem. First,  the intraeyto- 
plasmic domain of the receptor is composed of three amino 
acids that offer no specific clues about the mechanism of sig- 
naling.  Second, Igs are associated with several other poly- 
peptides on the cell surface to form a multi-subunit structure 
(1-4). Two of these receptor-associated polypeptides, Igc~ and 
Ig/3, have been implicated in receptor assembly and cell sur- 
face transport (3,  5).  In addition, both Igc~ and Ig/3 share 
a consensus sequence with signaling proteins of the T  cell 
and Fc receptors (6).  Crosslinking surface Ig leads to phos- 
phorylation  of Igc~ and  Ig~  and  activation  of receptor- 
associated kinases (4,  7-11).  Indeed, functional Ig antigen 
receptors can be reconstituted in T cells by cotransfection of 
IgM, Igol, and Ig~ and a direct physical link between the 
cytoplasmic domains of Igct and Ig~ and intracellular kinases 
has been proposed (12, 13). Although these experiments sug- 
gest an important role for the Igol-IgB complex in signal 
transduction,  the key questions of how the Igs are linked 
to the associated proteins, and whether Igct and Ig3 mediate 
signaling in B cells have not been resolved. To address these 
issues we have examined B cell lines that carry Igs with specific 
transmembrane mutations that impede signal transduction 
(14-17). 
Materials and Methods 
DNA Constructs.  Unique BamHI, and NotI sites surrounding 
the membrane exons of human IgM were placed in p468, a con- 
struct that contains Ig H and L chain genes (13). The membrane 
exons were then subcloned, and 587-588 YS/VV, as well as an in- 
frame unique NcoI-XbaI linker were inserted at position 594 by 
site-directed mutagenesis (p509). Igor and Ig/~ cytoplasmic tails and 
mutant versions with NcoI and XbaI sites at the 5' and 3' ends 
were amplified from plasmids (10467 and p466, respectively [13]) 
by PCR. After sequence  rerification, the PCR fragments were sub- 
cloned in-frame at the end of the Ig transmembrane domain. The 
modified membrane exons were then reinserted into the Ig in ex- 
pression vector (p468) by unique BamHI  and NotI sites (p520 
IgM:Ig/3; p523 IgM:Igot; p519 IgM:Ig/3-Y/F 206). 
Cell Lines.  A20 cells were grown in RPMI-1640 supplemented 
with 5% bovine calf serum, 50 U/ml penicillin, 50/zg/ml strep- 
tomycin, and 2 mM L-glutamine.  Cells were transfected with linear 
plasmid DNA by electroporation (17a). Selection was carried out 
with 550/zg/ml G418 (Gibco BRL, Grand Island, NY).  Trans- 
fected cells were enriched for surface Ig expression  by staining with 
fluorescein goat anti-human IgM (Southern Biotechnology As- 
sociates, Birmingham, AL), and sorting on a FACStar Plus  |  (Becton 
Dickinson & Co., Mountain View, CA). Analysis  of surface  staining 
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biotinylated monoclonal anti-human IgM and fluorescein-strepta- 
vidin (Pharmingen, San Diego, CA) using a FACScan  |  (Becton 
Dickinson & Co.). 
Abs.  5 mg of  purified  polyelonal  goat anti-human IgM or goat 
anti-mouse IgG2a (Southern  Biotechnology  Associates)  were preab- 
sorbed on 1 mg of mouse IgG2a or human IgM, respectively  cou- 
pled to cyanogen  bromide-activated Sepharose  4B (Pharmacia  Fine 
Chemicals, Piscataway,  NJ). The polyclonal  Abs did not crossreact 
as measured by staining and immunoprecipitation. Monoclonal 
anti-human IgM (18) was purified and modified as previously de- 
scribed (13). Abs specific  for Igo~  and IgB were produced in rabbits 
by immunization with fusion proteins that combined the cyto- 
plasmic domain of Igc~ or Igfl with glutathione S-transferase (19). 
Both sets of Abs immunoprecipitated  a disulfide-linked  heterodimer 
from B cells, and from T cells transfected  with IgM, Igcr  and IgB. 
Neither of the two Abs reacted with extracts from untransfected 
T cells (data not shown). In immunoblots, the anti-Iga Ab re- 
vealed a single 30-Kd protein in B cell lysates  or T cells transfected 
with Igol. The anti-Igt8 Ab blotted a set of three 32-, 37-, and 
39-Kd proteins from B cells, and IgB transfected T cells. There 
was no crossreactivity between the anti-Igc~ and Ig/3 Abs. 
ImmunoprecilJitation and Imrnunoblotting.  For coimmunoprecipi- 
tation experiments  cells  were lysed  in 1% n-dodecyl-B-D-maltoside 
(Anatrace, Maumee, OH) or 1% digitonin (Sigma Chemical Co., 
St. Louis, MO), 50 mM Tris, pH 6.8, 100 mM NaC1. Insoluble 
material was removed  by centrifugation and the supernatant frac- 
tion was incubated  with either goat anti-mIgG2a  or goat anti-hIgM 
coupled directly to cyanogen bromide-activated Sepharose (Phar- 
macia Fine Chemicals). Immune complexes  were collected, washed 
in lysis buffer, separated by 9% reducing SDS-PAGE, and trans- 
ferred to Immobilon-P (Millipore Co., Bedford, MA) in a semi- 
dry transfer  system  (Owl Scientific  Plastics, Cambridge, MA). After 
incubation with blotting Abs, labeled  proteins were visualized  with 
12sI-protein A (New England Nuclear, Boston, MA), using either 
a Phosphorimager (Molecular  Dynamics, Sunnyvale,  CA), or x-ray 
film. 
Induction of Tyrosine Phosphorylation.  Transfected A20 cells (2 
x  107/ml)  were crosslinked at 37~  with 20 #g/ml of anti-IgG2a 
or 10 #g/ml monoclonal anti-human IgM (18) for the indicated 
times in minutes. The cells were lysed with 1% NP-40, 10 mM 
Tris-HC1,  150  mM  NaC1,  2  mM  EDTA,  10  #g/ml 
aprotinin/leupeptin,  100 #M Na3VO4, pH 8, and the insoluble 
material was removed by centrifugation.  Phosphotyrosine-con- 
taining proteins were immunoprecipitated  with antiphosphotyrosine 
monoclonal  PY20 (ICN  Biochemicals, Cleveland,  OH)  and 
formalin-fixed  Staphylococcus  aureus (Pierce, Rockford, IL). Proteins 
were resolved  on 9% SDS-PAGE, transferred to nitrocellulose, and 
immunoblots  were performed  with  a  rabbit  polyclonal an- 
tiphosphotyrosine  antiserum (19). Labeled  proteins were visualized 
with ~251-protein A. 
Ca  2+ Flux Measurements.  Cells  loaded with Fura-2 (Molecular 
Probes Inc., Eugene, OK) were assayed  spectrofluorimetrically  for 
calcium mobilization (13) in response to 60/zg/ml of polyclonal 
anti-human  IgM or 40/zg/ml of anti-IgG2a. 
Results and Discussion 
Ig Transmembrane Mutations Destabilize the B  Cell Antigen 
Rec~tor.  A20 B lymphoma  calls transfected with phosphoryl- 
choline binding Igs were used to determine whether muta- 
tions in the Ig transmembrane domain would effect the in- 
teractions between Ig and the Igot-IgB complex (15) (Fig. 
1). We chose A20 cells because these cells express high levels 
of introduced Ig, and they also express endogenous IgG2a 
that can serve as a positive control (15). A20 cells efficiently 
present  antigen  through  IgG2a,  and  crosslinking  IgG2a 
produces  a  Ca  2+  flux (15). Furthermore, A20 cells  trans- 
fected with IgM are competent to signal through either IgM 
or IgG2a, and hybrid IgM-IgG2a Igs are not detected (15). 
Analysis of membrane Ig mutations has defined two dis- 
tinct groups of mutants that interfere with signal transduc- 
tion (14-17).  The first group, represented by deletion of the 
COOH-terminal three amino acids of the Ig H chain (cyto:A), 
results in an inositol-anchored IgM that binds antigen but 
does not induce a calcium response  or present antigen (15, 
20). The second group of mutations involves the polar amino 
acids in the Ig transmembrane domain (14-17). Altering these 
polar residues has effects on both signal transduction and trans- 
Figure  1.  Association  of Igor  and Ig/$  is mediated  through  polar  amino 
acids in the transmembrane  domain  of immunoglobulin.  (A) Transmem- 
brane and cytoplasmic  domains of IgM, mutant Igs, and chimeric  pro- 
teins. Identity  with the wild-type  protein is indicated  with a dash, and 
amino  adds  differences  are as shown. (B) Immunoprecipitation  of  Ig receptor 
complexes  from  transfected  A20 cells. IgG2a  and IgM receptor  complexes 
were independently  immunoprecipitated  with Sepharose-coupled goat 
anti-mouse  IgG2a  or anti-human  IgM. The blots  were  then probed  with 
Abs to Igor, Ig/~, or human IgM. (C) Comparison  of dodecyl-maltoside 
and digitonin  for coimmunoprecipitation  of Ig receptor complexes. A20 
cells were solubilized  in either 1% dodecyl-maltoside  or 1% digitonin, 
and immune  complexes  analyzed  by SDS-PAGE  followed  by blotting  with 
anti-lgot. (WT) Wild-type  human  IgM; (cytc~'A)  deletion  of KVK cyto- 
plasmic amino  adds; (YS/VV)  rephcement  of  both tyrosine  587, and serine 
588 with valine  in the Ig transmembrane  domain; (IgM:Igce)  fusion  pro- 
tein composed of nucleotides  encoding  amino acids 160-220 of Igce with 
the extracellular  and transmembrane  domain  of YS/W IgM; (IgM:IgB) 
fusion protein composed of nucleotides  encoding  amino acids 181-228 of 
Ig~ with the extracdlular  and transmembrane  domain  of YS/W IgM; 
(3/) immunoprecipitation  with anti-IgG2a;  (#) immunoprecipitation  with 
anti-IgM; (Igor) anti-Igce  immunoblot;  (IgB) and-IgB  immunoblot;  (IgM) 
anti-IgM immunoblot; (DM) immunoprecipitation in  1%  dodecyl- 
maltoside; (DI) immunoprecipitation  in 1% digitonin. 
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anchorage (14-17,  20).  For example,  introduction of non- 
polar groups such as val-val in place of Tyr-Ser at position 
587-588 (YS/W) produces a receptor that can no longer pro- 
duce a calcium flux or present antigen (15). Similar changes 
also result in an Ig whose transport to the cell surface is inde- 
pendent of coexpression of Igor and Ig3 (14). One explana- 
tion for these observations is that the polar amino acids in 
the Ig transmembrane domain bridge IgM and the Igot-Ig~ 
heterodimer. 
We used Abs to the cytoplasmic domains of Igor and Ig3 
determine whether specific Ig transmembrane mutations that 
interfere with signal transduction also disrupt the associa- 
tion of IgM with Igot-Ig~. Endogenous and transfected Igs 
were immunoprecipitated  with specific  anti-IgM or anti-IgG2a 
Abs, and the associated proteins were detected by Western 
blotting with anti-Igor or anti-Ig~. Endogenous IgG2a ex- 
pressed by the A20 cells was always associated with both Igor 
and Ig3. When A20 cells were transfected  with wild-type 
IgM, Igc~ and Ig3 were coimmunoprecipitated with both 
the transfected IgM and endogenous IgG2a (Fig.  1 B).  In 
contrast, the cyto:A and YS/VV mutant IgM H chains that 
neither present antigen nor signal were not associated with 
the Igcz-Ig3 heterodimer. Neither Igor nor Ig3 was coim- 
munoprecipitated with either of the two mutant Igs despite 
high level expression on the surface of transfected A20 cells 
(15) (Fig.  1 B). Since both the cyto:A and the YS/VV H 
chain proteins have a normal extracellular  domain, expres- 
sion of this domain is not sufficient to mediate the interac- 
tion between IgM and Igot-Ig/3. This observation may ex- 
plain why synthesis of the secreted form of IgM does not 
interfere with the assembly of membrane Ig antigen receptors. 
Our results,  and those of other investigators (3, 14) sug- 
gested an important role for the transmembrane or cytoplasmic 
domains in stabilizing the IgM/Igc~-Ig3 receptor complex 
(3,  14). Both the cyto:A and YS/VV mutations specifically 
alter the transmembrane domain. The cyto:A mutant does 
so by producing an Ig protein that is anchored to the plasma 
membrane by an inositol linkage (20). Finding that this mu- 
tation destroys the normal noncovalent interactions between 
IgM and Igot-Ig3 implied that transmembrane domain is re- 
quired for this interaction. The YS/VV mutation pinpoints 
essential amino acids since altering these two polar residues 
destabilizes  the IgM/Igot-Ig3 complex, without changing 
Ig membrane anchorage (15, 20).  The polar groups in the 
Ig transmembrane domain may interact with like residues 
in the transmembrane domains of Igor and Ig~ to stabilize 
the IgM/Igot-Ig3 receptor complex. This type of interac- 
tion is similar to that described for the ot and 3  chains of 
the TCR (21, 22), and appears to be another common theme 
in the family of immune recognition receptors (23). The IgM 
we used was human and the Igor and Ig3 were mouse, but 
the key amino acids are completely conserved in IgM between 
species (24). This human IgM is functional in transgenic mice 
for allelic exclusion and induction of B cell development, and 
can trigger normal proliferative responses when crosslinked 
in mature B cells (25, 26). Further, similar mutations in mouse 
IgM have effects on receptor transport that were consistent 
with uncoupling of Ig from Igor and Ig3 (14). Other combi- 
nations of human and mouse receptor components may be 
less favorable. For instance,  the combination of human Igor 
with mouse Ig3 leads to inefficient transport of mouse IgM 
to the cell surface (3). However the degree of conservation 
between human and mouse Igct is only 68% overall, and 56% 
in the extracellular  domain which is required for intrachain 
disulfide bond formation between Igor and Igfl (27). We con- 
clude that the polar groups in the Ig transmembrane domain 
are essential contact points for Igot-Ig3. In addition there 
is a strong correlation between receptor activity and the ability 
of the immunoglobulin heavy chain to form a stable com- 
plex with Igot-Ig~. 
Ig Transmembrane Mutations Interfere with Activation of Tyro- 
sine Phosphorylation.  To further explore the functional signifi- 
cance of the association  of Igot-Ig~ with Ig, we examined 
the effects of the cyto:A and YS/VV mutations on the in- 
duction of phosphorylation by receptor crosslinking. A20 cell 
lines transfected with the mutant Igs were stimulated with 
anti-IgM or anti-IgG2a, and phosphorylation of cellular sub- 
strates was assayed in immunoblotting  experiments with an- 
tiphosphotyrosine Abs. In control cell lines, crosslinking of 
membrane IgG2a induced a rapid increase in tyrosine phos- 
phorylation, and in A20 cells transfected with wild-type IgM 
this response was ehcited by crosslinking either IgM or IgG2a 
(Fig. 2). In contrast, the cyto:A mutation, which creates an 
inositol-anchored form of IgM, completely destroys the ability 
of the antigen receptor to stimulate tyrosine phosphoryla- 
tion. The YS/W mutation, which also uncouples the receptor 
from Ig~-Ig3, dramatically reduces the induction phosphory- 
lation but does not completely eliminate this response. This 
small amount of phosphorylation is reproducible, and not 
a function of crossreactivity since there is no response in cyto:A 
mutant or untransfected A20 cells (Fig. 2). One explanation 
for the low level activation by the mutant receptor is that 
the active conformation of Ig that is induced by crosslinking 
interacts weakly with Igot-Ig/~. Diminution of the response 
in YS/W may reflect the difference between a physical linkage 
of the components in the wild-type receptor, and a diffusion 
limited process in the mutant. 
The Cytoplasmic Domains of Igor and Ig~ Are Sufficient to 
Reconstitute Signaling.  The finding that Igs that fail to signal 
also fail to associate with Igot-Igfl is consistent with the hy- 
pothesis that the Igot-Ig3 heterodimer mediates signal trans- 
duction (6). To test this notion directly we produced chimeric 
receptors composed of the extracellular  and transmembrane 
domains of YS/VV mutant Igs fused with the cytoplasmic 
domains of either Igct or Ig3. The mutant Igs were attrac- 
tive candidates for reconstitution experiments since they do 
not interact with endogenous Igot-IgB (Fig. 1 B), but con- 
tain sequences that could be important for interaction with 
other as yet unidentified cellular factors.  Chimeric Ig pro- 
teins were transfected into the A20 B cell line, and high level 
expression was obtained by cell sorting (Fig. 3 B). We found 
that the chimeras did not associate with endogenous Igot- 
Ig3 (data not shown), nevertheless the recombinant proteins 
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stroys phosphorylation responses to receptor cross- 
linking in A20 cells. Transfected  A20 cells (2  x 
107/ml) cell lines were crosslinked at 37~  with 20 
/~g/ml  of  anti-lgG2a  or  10  pg/ml  monoclonal 
anti-human  IgM  (18) for the indicated times in 
minutes. Phosphoproteins  were visualized by immu- 
noblotting. (Le~) Molecular weights (I~1). (,4,20)  Un- 
transfected A20 cells; (Wt lgM)  A20 cells transfected 
with wild-type IgM; (cyt~x.A)  A20 cells transfected 
with the cyto:A Ig construct; (YS/VV) A20 cells 
transfected  with the YS/VV mutant Ig. 
were able to reconstitute Ca  2  + responses (Fig. 3 C). Cross- 
linking the transfected IgM:Igol or IgM:Ig3 chimeras with 
anti-IgM  results  in  a  Ca  2+  flux,  whereas  the  parental 
YS/VV Ig was inactive  (15, Fig.  3 C).  The consensus se- 
quence shared by Igol, Ig3, TCR, and FcR components in- 
cludes tyrosines that have been shown to be essential for func- 
tion (28).  To examine the role of the conserved tyrosines, 
Tyr 206 in Ig/3 was changed to Phe in the IgM:Ig/3 chimera 
(IgM:Ig3-Y/F). This single change was suf~cient to destroy 
the activity of the IgM:Ig/3 in Ca  2+  flux experiments, but 
did not alter Ca  2. responses induced by crosslinking endog- 
enous membrane IgG2a (Fig. 3, C  and/9). Thus the Ca  2+ 
response is dependent upon the presence of the conserved tyro- 
sine at position 206 of Ig/3. When the same cell lines were 
tested for induction of phosphorylation by receptor cross- 
linking, we found that only the Igc~  chimera was active (Fig. 
3 E). Crosslinking the IgM:Igot chimera induced rapid tyro- 
sine phosphorylation of a number of cellular proteins, whereas 
IgM:Ig3 chimera did not give an appreciable response above 
the background (Fig.  3 E).  Thus, both Igcz and Ig3 cyto- 
plasmic domains were active in transferring signaling activity 
to YS/VV Ig, but there is a difference in their range of ac- 
tivity. Both stimulated Ca  2  + flux but only Igo~ was able to 
induce the rapid phosphorylation of a large number of cel- 
lular substrates.  Further, the signaling mechanism for Ca  2+ 
flux is dependent on tyrosine 206 in Igl3 which is part of 
a consensus sequence shared with other immune recognition 
receptors.  The role of the conserved tyrosines in this con- 
sensus sequence has not been clearly elucidated. However, 
the corresponding residues in the TCR-~" chain are rapidly 
phosphorylated upon receptor activation, and only the phos- 
phorylated forms of ~" are associated with the zap-70 kinase 
(29, 30). Components of the Ig receptor have been associated 
with a number of different kinases including Lyn, Fyn, Blk, 
and Syk which is highly homologous to Zap-70  (7, 8,  29, 
31). In B cells, Igc~ and Igi3 may serve to connect IgM with 
cellular kinases by binding directly to SH2 domains. Elegant 
structural studies of src SH2 domains have  demonstrated that 
the interaction of SH2 with peptides is through phosphotyro- 
sine and isoleucine binding pockets spaced by two amino acids 
(32-34).  The consensus found in the immune recognition 
receptors includes at least two YXXL/I repeats that would 
be predicted to interact with the SH2 domains of Src family 
kinases (32-35). Indeed the cytoplasmic tails of Igtx and Ig~ 
bind to two different sets of kinases in cellular extracts (12). 
These in vitro experiments suggested that Igol and Ig3 may 
mediate different signaling functions through interactions with 
different kinases.  A  number of cellular  and developmental 
events in B cells are regulated by membrane Ig (25, 36-39). 
These events could all be mediated through the Igc~-Igj3  het- 
erodimer, or through individual receptor components inter- 
acting with different sets of kinases. Our finding that Igcr 
and Ig3 have different signaling activities, provides evidence 
that Igc~ and IgB can mediate independent physiologic pro- 
cesses in vivo. 
These studies were designed to elucidate the molecular re- 
quirements for Ig receptor function. A  key aspect  of the 
strategy we used was specific Ig transmembrane mutations 
that were known to interfere with signal transduction. We 
have shown that association of IgM with Igcc-Igfl is required 
to produce a functional B cell antigen receptor.  That signal 
transduction can be reconstituted with the cytoplasmic do- 
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tute Ca  2+ and phosphorylation  responses in YS/W mutant 
Igs. (A) Diagrammatic  representation of  DNA constructs  that 
encode IgM and chimeric Igs. (/3) Flow cytometric analysis 
of  surface expression of chimeric human  Ig  constructs 
(IgM:Igr~  p523, IgM:IgB p520, IgM:IgB Y206/F p519, Fig. 
1 A)  transfected into  A20 B cell lines and stained with 
fluorescein-labded anti-human IgM (Southern Biotechnology 
Associates). Unstained cells are the negative control in each 
case. (Tbp) Transfected constructs. (C) Ca  z+ flux in response 
to anti-IgM in A20 calls transfected with chimeric Igs. (D) 
Ca  z+ flux in response to control anti-lgG2a  in the transfected 
A20 ceils. (E) Induction of tyrosine  phosphorylation  by cross- 
linking with anti-IgM or anti-IgG2a in A20 calls transfected 
with chimeric  receptors. (IgM:lgo  0 A20 cells transfected  with 
chimeric Ig-Igcr  (IgM:Igfl) A20 cells transfected with chi- 
meric Ig-Ig~; (lgM:Igfl-Y/F)  A20 cells transfected with mu- 
tant chimeric IgM:Igfl in which Tyr 206 in Igfl has been 
changed to Phe; anti-IgM, cells crosslinked with anti-lgM 
Abs; anti-IgG2a, cells crosslinked with  anti-IgG2a Abs. 
mains of Igor and Ig~ implies that these sequences are also 
sufficient to mediate signaling.  However Igol and Ig/3 had 
different  biological activities  suggesting that each of these 
molecules may have unique functions in B cell development 
and activation. The chimeric receptors that we have described, 
composed of mutant Igs and individual signaling components, 
should provide a powerful new tool for the further analysis 
of the physiologic  role of Igc~ and Ig~. 
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